Article Poly(I:C) suppresses NF1-associated optic pathway glioma growth through TLR3-dependent and TLR3-independent modulation of microglial ERK signaling Jit ChatterjeeElvedina SubasicDavid H. Gutmann in Acta Neuropathologica Communications 23 October 2026 Open Access
Article Human single cell RNA-sequencing reveals a targetable CD8+ exhausted T cell population that maintains mouse low-grade glioma growth Rasha BarakatJit ChatterjeeDavid H. Gutmann in Nature Communications 28 November 2024 Open Access
Article Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice Yuan PanJared D. HysingerMichelle Monje in Nature Neuroscience 30 May 2024 Open Access
Article Brain injury drives optic glioma formation through neuron-glia signaling Jit ChatterjeeJoshua P. KoleskeDavid H. Gutmann in Acta Neuropathologica Communications 2 February 2024 Open Access
Chapter Neurofibromatosis Type 1 Mouse Models Jit ChatterjeeJoshua P. KoleskeDavid H. Gutmann in The RASopathies 1 January 2024
Article Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma Zhihong ChenNishant SoniDolores Hambardzumyan in Nature Communications 3 April 2023 Open Access
Article Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling Corina AnastasakiJit ChatterjeeDavid H. Gutmann in Acta Neuropathologica Communications 19 August 2022 Open Access
Article Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1 Corina AnastasakiJuan MoDavid H. Gutmann in Nature Communications 19 May 2022 Open Access
Article Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia Jit ChatterjeeShilpa SanapalaDavid H. Gutmann in Nature Communications 8 December 2021 Open Access
Article NF1 mutation drives neuronal activity-dependent initiation of optic glioma Yuan PanJared D. HysingerDavid H. Gutmann in Nature 26 May 2021
Article Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1) Michael J. FisherDavid T. W. JonesDavid H. Gutmann in Acta Neuropathologica 14 February 2021
Article Midkine activation of CD8+ T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth Xiaofan GuoYuan PanDavid H. Gutmann in Nature Communications 1 May 2020 Open Access
Article Correction to: Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma Verena HaageMarcus SemtnerDavid H. Gutmann in Acta Neuropathologica Communications 8 January 2020 Open Access
Article Reply to ‘Assembling the brain trust: the multidisciplinary imperative in neuro-oncology’ Kenneth AldapeKevin M. BrindleRichard J. Gilbertson in Nature Reviews Clinical Oncology 31 May 2019
Article Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma Verena HaageMarcus SemtnerDavid H. Gutmann in Acta Neuropathologica Communications 14 February 2019 Open Access
Article Challenges to curing primary brain tumours Kenneth AldapeKevin M. BrindleRichard J. Gilbertson in Nature Reviews Clinical Oncology 7 February 2019 Open Access
Article Variability of Betweenness Centrality and Its Effect on Identifying Essential Genes Christina DurónYuan PanAmi Radunskaya in Bulletin of Mathematical Biology 22 October 2018
Article Tumor suppressor Tsc1 is a new Hsp90 co‐chaperone that facilitates folding of kinase and non‐kinase clients Mark R WoodfordRebecca A SagerMehdi Mollapour in The EMBO Journal 10 November 2017 Open Access
Article Neurofibromatosis type 1 David H. GutmannRosalie E. FernerKimberly J. Johnson in Nature Reviews Disease Primers 23 February 2017
Article The role of microglia and macrophages in glioma maintenance and progression Dolores HambardzumyanDavid H GutmannHelmut Kettenmann in Nature Neuroscience 29 December 2015
Article Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1 Bree PorcelliNancy L. ZoellnerKimberly J. Johnson in Familial Cancer 14 December 2015
Article HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1 A OmraniT van der VaartY Elgersma in Molecular Psychiatry 28 April 2015
Article The adhesion GPCR Gpr56 regulates oligodendrocyte development via interactions with Gα12/13 and RhoA Sarah D. AckermanCynthia GarciaKelly R. Monk in Nature Communications 21 January 2015
Article Parental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative Qian LiuNancy ZoellnerKimberly J. Johnson in Familial Cancer 10 December 2014
Article Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas Melike PekmezciDavid E ReussArie Perry in Modern Pathology 5 September 2014
Article Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis Chinwe C. MadubataMargaret A. OlsenKimberly J. Johnson in Genetics in Medicine 5 June 2014
Article Advances in the treatment of neurofibromatosis-associated tumours Andrew L. LinDavid H. Gutmann in Nature Reviews Clinical Oncology 13 August 2013
Article Erratum to: Optic nerve tortuosity in children with neurofibromatosis type 1 Joyce JiJoshua ShimonyDavid H. Gutmann in Pediatric Radiology 10 June 2013
Article Optic nerve tortuosity in children with neurofibromatosis type 1 Joyce JiJoshua ShimonyDavid H. Gutmann in Pediatric Radiology 2 May 2013
Article The molecular and cell biology of pediatric low-grade gliomas Y-H ChenD H Gutmann in Oncogene 29 April 2013
Article BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma Sonika DahiyaDevon H. HaydonJeffrey R. Leonard in Acta Neuropathologica 23 April 2013
Article Merlin isoform 2 in neurofibromatosis type 2–associated polyneuropathy Alexander SchulzStephan L BaaderHelen Morrison in Nature Neuroscience 3 March 2013
Article NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma A C SolgaS M GianinoD H Gutmann in Oncogene 14 January 2013
Article miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells N KlieseP GobrechtC Mawrin in Oncogene 29 October 2012
Article Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research Robert A. AveryRosalie E. FernerGrant T. Liu in Journal of Neuro-Oncology 28 July 2012
Article Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas K. J. JohnsonM. J. FisherD. H. Gutmann in Familial Cancer 25 July 2012
Chapter NF1-Associated Optic Glioma Anne C. SolgaDavid H. Gutmann in Neurofibromatosis Type 1 1 January 2012
Protocol Using Genetically Engineered Mouse Models to Understand Low-Grade Glioma Development and Growth in Children Aparna KaulIbrahim HussainDavid H. Gutmann in Animal Models of Brain Tumors 1 January 2012
Article Identification of transcriptional regulatory networks specific to pilocytic astrocytoma Hrishikesh DeshmukhJinsheng YuRakesh Nagarajan in BMC Medical Genomics 11 July 2011 Open Access
Journal Acta Neuropathologica Communications Acting as the sister journal to Acta Neuropathologica, Acta Neuropathologica Communications publishes high quality research and reviews to a global... Publishing model Open access Journal Impact Factor 6.5 (2025) Downloads 2.8M (2025) Submission to first decision (median) 9 days
Journal Nature Communications Nature Communications is an open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological,... Publishing model Open access Journal Impact Factor 18.1 (2025) Downloads 349.9M (2025) Submission to first decision (median) 9 days
Journal Nature Neuroscience Nature Neuroscience provides the international neuroscience community with a highly visible forum in which the most exciting developments in all... Publishing model Hybrid Journal Impact Factor 20.3 (2025) Downloads 9.9M (2025) Submission to first decision (median) 9 days